According to the latest report by IMARC Group “Brain Implants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026“, The global brain implants market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 9% during 2021-2026.
Brain implants are technological devices that are placed inside the human body to interact with neurons. These systems facilitate communication between the brain and electronic devices for recording, translating and modifying brain activity. They are commonly used for understanding brain functions, rehabilitating one’s body after an injury, improving memory and communicating with prosthetic limbs.
Request for a free sample copy of this report: https://www.imarcgroup.com/brain-implants-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
The global market is majorly driven by the increasing incidences of neurological diseases across the globe. With the growing geriatric population and the rising prevalence of age-related neurological disorders on the global level, there has been a considerable increase in the requirement for deep brain stimulation (DBS) procedures for the treatment of dystonia, tinnitus, epilepsy, neuropathic pain, Alzheimer’s and Parkinson’s disease. Since brain implants form an essential component in DBS, this is creating a positive outlook for the market. The market is further driven by the continual research and development (R&D) activities conducted by key players to develop carbon nanotubes and conventional silicone implants to be used as brain implants that are expected to offer improved sensory results among amputees and injured athletes.
Breakup by Product:
- Deep Brain Stimulators
- Spinal Cord Stimulators
- Vagus Nerve Stimulators
Breakup by Application:
- Chronic Pain
- Parkinson’s Disease
- Essential Tremor
- Alzheimer’s Disease
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Abbott Laboratories
- Aleva Neurotherapeutics SA
- Boston Scientific Corporation
- Cochlear Ltd.
- Edwards Lifesciences Corporation
- Ndi Medical LLC
- NeuroPace Inc.
- Nevro Corp.
- Synapse Biomedical Inc
- Synchron Inc.
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/brain-implants-market
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want latest primary and secondary data (2021-2026) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800